The impact of depression on the treatment of obsessive-compulsive disorder: Results from a 5-year follow-up

Journal of Affective Disorders

Volumn 135, Issue 1-3, 2011, Pages 201-207

  Anholt, Gideon E ^a,b   Aderka, Idan M ^c   Van Balkom, Anton J L M ^a   Smit, Johannes H ^a   Hermesh, Haggai ^d,e   De Haan, Els ^f   Van Oppen, Patricia ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BOSTON UNIVERSITY   (United States)

^d GEHA MENTAL HEALTH CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Depression; Obsessive compulsive disorder; Pharmacotherapy; Psychotherapy

Indexed keywords

FLUVOXAMINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; COGNITIVE THERAPY; DEPRESSION; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUVOXAMINE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PREDICTIVE VALUE OF TESTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054993004     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.07.018     Document Type: Article

References (48)

1. J.S. Abramowitz Treatment of obsessive-compulsive disorder in patients who have comorbid depression J. Clin. Psychol. 60 2004 1133 1141
2. J.S. Abramowitz, and E.B. Foa Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD Behav. Ther. 31 2000 795 800
3. J. Angst, A. Gamma, J. Endrass, R. Goodwin, V. Ajdacic, D. Eich, and W. Rössler Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course Eur. Arch. Psychiatry Clin. Neurosci. 254 2004 156 164
4. G.E. Anholt, P. van Oppen, P.M.G. Emmelkamp, D.C. Cath, J.H. Smit, R. van Dyck, and A.J.L.M. van Balkom Measuring obsessive-compulsive symptoms: Padua Inventory-Revised vs Yale-Brown Obsessive-Compulsive Scale. J Anxiety Disord. 23 2009 830 835
5. G.E. Anholt, P. van Oppen, D.C. Cath, P.M.G. Emmelkamp, J.H. Smit, and A.J.L.M. van Balkom Sensitivity to change of the obsessive beliefs questionnaire Clin. Psychol. Psychother. 17 2010 154 159
6. P.E. Bebbington Epidemiology of obsessive-compulsive disorder Br. J. Psychiatry 173 Suppl. 35 1998 2 6
7. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch. Gen. Psychiatry 4 1961 561 571
8. A.T. Beck, R.A. Steer, and M.G. Garbin Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation Clin. Psychol. Rev. 8 1988 77 100
9. M.J. Boschen, L.M. Drummond, A. Pillay, and K. Morton Predicting outcome of treatment for severe, treatment resistant OCD in inpatient and community settings J. Behav. Ther. Exp. Psychiatry 41 2010 90 95
10. M.G. Craske, T.J. Farchione, L.B. Allen, V. Barrios, M. Stoyanova, and R. Rose Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more? Behav. Res. Ther. 45 2007 1095 1109
11. R.D. Crino, and G. Andrews Obsessive-compulsive disorder and axis I comorbidity J. Anxiety Disord. 19 1996 37 46
12. P.A. DiNardo, G.T. O'Brien, D.H. Barlow, M.T. Waddell, and E.B. Blanchard Reliability of DSM-III anxiety disorders categories using a new structured interview Arch. Gen. Psychiatry 40 1983 1070 1075
13. P.L. Fisher, and A. Wells How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis Behav. Res. Ther. 43 2005 1543 1558
14. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, P. Delgado, G.R. Heninger, and D.S. Charney The Yale-Brown obsessive compulsive scale: II validity Arch. Gen. Psychiatry 46 1989 1012 1016
15. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, R. Fleischmann, C.L. Hill, G.R. Heninger, and D.S. Charney The Yale-Brown obsessive-compulsive scale I: development, use, and reliability Arch. Gen. Psychiatry 46 1989 1006 1011
16. J. Hong, J. Samuels, O.J. Bienvenu, P. Cannistraro, M. Grados, M. Riddle, K.Y. Liang, and B. Cullen Clinical correlates of recurrent major depression in obsessive-compulsive disorder Depress. Anxiety 20 2004 86 91
17. J.D. Huppert, H.B. Simpson, K.J. Nissenson, M.R. Liebowitz, and E. Foa Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls Depress. Anxiety 26 2009 39 45
18. M.L. Keeley, E.A. Storch, L.J. Merlo, and G.R. Geffken Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder Clin. Psychol. Rev. 28 2008 118 130
19. G.P.J. Keijsers, C.A.L. Hoogduin, and C.P.D.R. Schaap Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder Br. J. Psychiatry 165 1994 781 786
20. P.T. Kempe, P. van Oppen, E. de Haan, J.W. Twisk, A. Sluis, J.H. Smit, R. van Dyck, and A.J.L.M. van Balkom Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events Acta Psychiatr. Scand. 116 2007 201 210
21. D.A. Kenny, D.A. Kashy, and N. Bolger D. Gilbert, S.T. Fiske, G. Lindzey, The handbook of social psychology 1998 New York McGraw-Hill 223 265
22. D.A. Kenny, J.D. Korchmaros, and N. Bolger Lower level mediation in multilevel models Psychol. Methods 8 2003 115 128
23. D.P. MacKinnon, M.S. Fritz, J. Williams, and C.M. Lockwood Distribution of the product confidence limits for the indirect effect: program PRODCLIN Behav. Res. Methods 39 2007 384 389
24. M.C. Mancebo, B. Greenberg, J.E. Grant, A. Pinto, J.L. Eisen, I. Dyck, and S.A. Rasmussen Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder Compr. Psychiatry 89 2008 43 50
25. P.D. McLean, M.L. Whittal, D.S. Thordarson, S. Taylor, I. Söchting, W.J. Koch, R. Paterson, and K.W. Anderson Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder J. Consult. Clin. Psychol. 69 2001 205 214
26. B. Millet, F. Kochman, T. Gallarda, M.O. Krebs, F. Dmonfaucon, I. Barrot, M.C. Bourdel, J.P. Olié, H. Loo, and E.G. Hantouche Phenomenological and comorbid features associated in obsessive-compulsive disorder: influence of age of onset J. Affect. Disord. 79 2004 241 246
27. D.A. Moscovitch, S.G. Hofmann, M.K. Suvak, and T. In-Albon Mediation of changes in anxiety and depression during treatment of social phobia J. Consult. Clin. Psychol. 73 2005 945 952
28. C.J. Murray, and A.D. Lopez The Global Burden of Disease 1996 Harvard University Press Boston, MA
29. J.K. Myers, M.M. Weissman, G.L. Tischler, C.E. Holzer, P.J. Leaf, H. Orvaschel, J.C. Anthony, J.H. Boyd, J.D. Burke, M. Kramer, and R. Stoltzman Six-month prevalence of psychiatric disorders in three communities Arch. Gen. Psychiatry 41 1984 959 970
30. G. Nestadt, J. Samuels, M. Riddle, K.Y. Liang, O. Bienvenu, R. Hoehn-Saric, M. Grodos, and B. Cullen The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study Psychol. Med. 31 2001 481 487
31. A.L. Raffin, J.M. Guimarães Fachel, Y.A. Ferrão, F. Pasquoto de Souza, and A.V. Cordioli Predictors of response to group cognitive-behavioral therapy in the treatment of obsessive-compulsive disorder Eur. Psychiatry 24 2009 297 306
32. S.W. Raudenbush Comparing personal trajectories and drawing causal inferences from longitudinal data Annu. Rev. Psychol. 52 2001 501 525
33. S.W. Raudenbush, and A.S. Bryk Hierarchical linear models: applications and data analysis methods 2001 Sage Newbury Park, CA 33 64
34. N.A. Rector, S.E. Cassin, and M.A. Richter Psychological treatment of obsessive-compulsive disorder in patients with major depression: a pilot randomized controlled trial Can. J. Psychiatry 54 2009 846 851
35. A.L. Rosa-Alcázar, J. Sánchez-Meca, A. Gómez-Conesa, and F. Marín-Martínez Psychological treatment of obsessive-compulsive disorder: a meta-analysis Clin. Psychol. Rev. 28 2008 1310 1325
36. E. Sanavio Obsessions and compulsions: the Padua inventory Behav. Res. Ther. 26 1988 169 177
37. M.B. Stein, D.R. Ford, G. Anderson, and J.R. Walker Obsessive compulsive disorder in the community: an epidemiological survey with clinical reappraisal Am. J. Psychiatry 154 1997 1120 1126
38. G. Steketee, and D.H. Barlow Obsessive-compulsive disorder D.H. Barlow, Anxiety and its Disorders: The Nature and Treatment of Anxiety and Panic 2004 Guilford Press New-York 516 550
39. G. Steketee, J. Eisen, I. Dyck, M. Warshaw, and S. Rasmussen Predictors of course in obsessive-compulsive disorder Psychiatry Res. 89 1999 229 238
40. G. Steketee, N.J. Henninger, and C. Pollard Predicting treatment outcomes for obsessive-compulsive disorder: effects of comorbidity W.K. Goodman, M.V. Rudorfer, J.D. Maser, Obsessive-Compulsive Disorder: Contemporary Issues in Treatment 2000 Lawrence Erlbaum Mahwah, NJ 257 274
41. G. Steketee, D.L. Chambless, and G.Q. Tran Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia Compr. Psychiatry 42 2001 76 86
42. S.E. Stewart, C.H. Yen, D.E. Stack, and M.A. Jenike Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment J. Psychiatr. Res. 40 2006 511 519
43. E.A. Storch, A.B. Lewin, L. Farrell, M.A. Aldea, J. Reid, G.R. Geffken, and T.K. Murphy Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities? J. Anxiety Disord. 24 2010 547 552
44. D.F. Tolin, N. Maltby, G.J. Diefenbach, S.E. Hannan, and P. Worhunsky Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial J. Clin. Psychiatry 65 2004 922 931
45. A.J.L.M. van Balkom, E. de Haan, P. van Oppen, P. Spinhoven, K.A. Hoogduin, and R. van Dyck Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder J. Nerv. Ment. Dis. 186 1998 492 499
46. P. van Oppen, E. de Haan, A.J.L.M. van Balkom, P. Spinhoven, K. Hoogduin, and R. van Dyck Cognitive therapy and exposure in vivo in the treatment for obsessive-compulsive disorder Behav. Resh. Ther. 33 1995 379 390
47. P. van Oppen, P.M.G. Emmelkamp, A.J.L.M. van Balkom, and R. van Dyck The sensitivity to change of measures for obsessive compulsive disorder J. Anxiety Disord. 9 1995 241 248
48. P. van Oppen, J.L.M. van Balkom, E. de Haan, and R. van Dyck Cognitive therapy, exposure in vivo and the combination with fluvoxamine in obsessive compulsive disorder: a 5-year follow-up J. Clin. Psychiatry 66 2005 1415 1422